David K. Lee is a seasoned veteran of the pharma industry dedicated to bringing innovative, responsible and life-changing products to patients. As CEO, David leads Servier Pharmaceuticals’ efforts to leverage Servier Group’s global portfolio and seek acquisitions, licensing deals and partnerships in the United States – a new frontier for the France-based global pharmaceutical company.

Throughout his career, David has held leadership positions at several industry-leading companies, including Shire, Baxalta and Novartis. Most recently, he served as Shire’s Head of the Global Genetic Disease and Oncology franchises, where he oversaw the cross-functional leadership teams. His career highlights include the approval of products for oncology and genetic diseases.

Energized by his mission to find cures for cancer and rare diseases, David spent time early in his career working at Partners in Health in Rwanda, the World Health Organization in Geneva and the Boston Medical Library. While at Novartis, he helped launch novel vaccines and orchestrated the successful cross-functional completion of various clinical trials. He has a passion for innovation that feeds his commitment to identifying partnerships to foster next-generation scientific discovery.

David received his Bachelor of Science in Biochemistry from Harvard University and his Master of Business Administration from Harvard Business School.